0.64
+0.0141(+2.26%)
Currency In USD
| Previous Close | 0.62 |
| Open | 0.64 |
| Day High | 0.66 |
| Day Low | 0.62 |
| 52-Week High | 2.95 |
| 52-Week Low | 0.5 |
| Volume | 237,989 |
| Average Volume | 492,004 |
| Market Cap | 11.34M |
| PE | -0.22 |
| EPS | -2.91 |
| Moving Average 50 Days | 0.62 |
| Moving Average 200 Days | 0.9 |
| Change | 0.01 |
If you invested $1000 in Lifeward Ltd. (LFWD) 10 years ago, it would be worth $0.27 as of January 06, 2026 at a share price of $0.638. Whereas If you bought $1000 worth of Lifeward Ltd. (LFWD) shares 5 years ago, it would be worth $59.53 as of January 06, 2026 at a share price of $0.638.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Lifeward Appoints Bob Marshall as Chairman of the Board
GlobeNewswire Inc.
Dec 19, 2025 9:05 PM GMT
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology designed to transform the lives of people with physical li
Lifeward Expands International Distribution of its ReWalk® Personal Robotic Exoskeleton into Mexico, Thailand, and the United Arab Emirates
GlobeNewswire Inc.
Dec 17, 2025 1:00 PM GMT
Distribution agreement with Singapore-based Verita Neuro will provide patients the ReWalk Personal Exoskeleton as part of its multi-layered treatment modalities New delivery model for ReWalk will integrate in-patient training and rehabilitation to su
Lifeward Broadens Reimbursement Coverage for ReWalk 7 Personal Robotic Exoskeleton as Humana Medicare Advantage Plan Issues Prior Authorization Approval
GlobeNewswire Inc.
Dec 03, 2025 1:00 PM GMT
Humana and UnitedHealthcare, which granted authorization in November, are the two largest Medicare Advantage providers in the U.S., accounting for 47% of all Medicare Advantage enrollees This latest approval will help enhance timely access to cutting